168 related articles for article (PubMed ID: 37480761)
1. Myeloid/Lymphoid Neoplasm with FGFR1 Rearrangement Presenting with Polycythemia Vera and T-cell Acute Lymphoblastic Leukemia.
Marinelli LM; Romain JT; Ehman W; Ortega V; Velagaleti G; Gibbons TF; Nazario-Toole A; Holmes AR
Cancer Genet; 2023 Aug; 276-277():43-47. PubMed ID: 37480761
[TBL] [Abstract][Full Text] [Related]
2. Myeloid and lymphoid neoplasm with abnormalities of FGFR1 presenting with trilineage blasts and RUNX1 rearrangement: a case report and review of literature.
Kumar KR; Chen W; Koduru PR; Luu HS
Am J Clin Pathol; 2015 May; 143(5):738-48. PubMed ID: 25873510
[TBL] [Abstract][Full Text] [Related]
3. Myeloid/lymphoid neoplasm with eosinophilia and BCR/FGFR1 rearrangement with transformation to cortical T-lymphoblastic lymphoma and erythroid precursors: a case report.
Isaza AP; Quintero SC; González LPQ; Córdoba FEA; Olivar AFA; Ocaña JCB
J Med Case Rep; 2023 Jan; 17(1):39. PubMed ID: 36698221
[TBL] [Abstract][Full Text] [Related]
4. Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase.
Montenegro-Garreaud X; Miranda RN; Reynolds A; Tang G; Wang SA; Yabe M; Wang W; Fang L; Bueso-Ramos CE; Lin P; Medeiros LJ; Lu X
Hum Pathol; 2017 Jul; 65():147-156. PubMed ID: 28551329
[TBL] [Abstract][Full Text] [Related]
5. FGFR1 translocation with concurrent myeloproliferative neoplasm, systemic mastocytosis, and lymphoblastic lymphoma: a case report.
Chang K; Liu JH; Yu SC; Lin CW
Hum Pathol; 2018 Apr; 74():114-121. PubMed ID: 29107667
[TBL] [Abstract][Full Text] [Related]
6. [FGFR1-mutated B-cell acute lymphoblastic leukemia transforming to myelodysplastic / myeloproliferative neoplasm and acute myeloid leukemia].
Ide S; Ohara S; Inoue M; Hua J; Hagihara M
Rinsho Ketsueki; 2018; 59(7):872-877. PubMed ID: 30078796
[TBL] [Abstract][Full Text] [Related]
7. Fine-needle aspiration cytology of T-lymphoblastic lymphoma associated FGFR1 rearrangement myeloproliferative neoplasm.
Patel RA; Sheehan AM; Finch CJ; Lopez-Terrada D; Hernandez VS; Curry CV
Diagn Cytopathol; 2014 Jan; 42(1):45-8. PubMed ID: 23904402
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangement.
Umino K; Fujiwara SI; Ikeda T; Toda Y; Ito S; Mashima K; Minakata D; Nakano H; Yamasaki R; Kawasaki Y; Sugimoto M; Yamamoto C; Ashizawa M; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Kanda Y
Hematology; 2018 Sep; 23(8):470-477. PubMed ID: 29486661
[TBL] [Abstract][Full Text] [Related]
9. Progression to B acute lymphoblastic leukemia in 8p11 myeloproliferative syndrome with t(6;8)(q27;p12).
Nakamura F; Seo S; Nannya Y; Ayabe R; Takahashi W; Handa T; Arai H; Iso H; Nakamura Y; Nakamura Y; Sasaki K; Ichikawa M; Imai Y; Ogawa S; Mitani K
Int J Hematol; 2023 Sep; 118(3):388-393. PubMed ID: 36930401
[TBL] [Abstract][Full Text] [Related]
10. Pemigatinib for the treatment of myeloid/lymphoid neoplasms with
Freyer CW; Hughes ME; Carulli A; Bagg A; Hexner E
Expert Rev Anticancer Ther; 2023 Apr; 23(4):351-359. PubMed ID: 36927350
[TBL] [Abstract][Full Text] [Related]
11. Myeloid/lymphoid neoplasms with FGFR1 rearrangement.
Strati P; Tang G; Duose DY; Mallampati S; Luthra R; Patel KP; Hussaini M; Mirza AS; Komrokji RS; Oh S; Mascarenhas J; Najfeld V; Subbiah V; Kantarjian H; Garcia-Manero G; Verstovsek S; Daver N
Leuk Lymphoma; 2018 Jul; 59(7):1672-1676. PubMed ID: 29119847
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of two rare BCR-FGFR1
Barnes EJ; Leonard J; Medeiros BC; Druker BJ; Tognon CE
Cold Spring Harb Mol Case Stud; 2020 Apr; 6(2):. PubMed ID: 31980503
[TBL] [Abstract][Full Text] [Related]
13. Myeloid/lymphoid neoplasm with
Chen D; Liu G; Lewis MR; Li X; Ulrickson M; Nath R; Chen W
Leuk Res Rep; 2023; 19():100370. PubMed ID: 37275466
[TBL] [Abstract][Full Text] [Related]
14. Molecular identification of a TPR-FGFR1 fusion transcript in an adult with myeloproliferative neoplasm, T-lymphoblastic lymphoma, and a t(1;8)(q25;p11.2).
Kim SY; Kim JE; Park S; Kim HK
Cancer Genet; 2014 Jun; 207(6):258-62. PubMed ID: 25037443
[TBL] [Abstract][Full Text] [Related]
15. Chromosome 9p24 abnormalities: prevalence, description of novel JAK2 translocations, JAK2V617F mutation analysis and clinicopathologic correlates.
Patnaik MM; Knudson RA; Gangat N; Hanson CA; Pardanani A; Tefferi A; Ketterling RP
Eur J Haematol; 2010 Jun; 84(6):518-24. PubMed ID: 20331734
[TBL] [Abstract][Full Text] [Related]
16. Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes.
Stein BL; Williams DM; O'Keefe C; Rogers O; Ingersoll RG; Spivak JL; Verma A; Maciejewski JP; McDevitt MA; Moliterno AR
Haematologica; 2011 Oct; 96(10):1462-9. PubMed ID: 21712540
[TBL] [Abstract][Full Text] [Related]
17. Clonal evolution of 8p11 stem cell syndrome in a 14-year-old Chinese boy: a review of literature of t(8;13) associated myeloproliferative diseases.
Wong WS; Cheng KC; Lau KM; Chan NP; Shing MM; Cheng SH; Chik KW; Li CK; Ng MH
Leuk Res; 2007 Feb; 31(2):235-8. PubMed ID: 16777224
[TBL] [Abstract][Full Text] [Related]
18. Precursor T-Lymphoblastic Lymphoma Associated with t(8;9)(p11.2;q33): A Case Report and Review of the Literature.
Lv H; Hu S; Lu J; Zhai Q; Zhai Z; Du Z; Sun Y; Li J; He H; Wang Y
Acta Haematol; 2018; 139(3):176-182. PubMed ID: 29614500
[TBL] [Abstract][Full Text] [Related]
19. A case of 8p11 myeloproliferative syndrome with BCR-FGFR1 gene fusion presenting with trilineage acute leukemia/lymphoma, successfully treated by cord blood transplantation.
Morishige S; Oku E; Takata Y; Kimura Y; Arakawa F; Seki R; Imamura R; Osaki K; Hashiguchi M; Yakushiji K; Mizuno S; Yoshimoto K; Nagafuji K; Ohshima K; Okamura T
Acta Haematol; 2013; 129(2):83-9. PubMed ID: 23171834
[TBL] [Abstract][Full Text] [Related]
20. Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or With PCM1-JAK2.
Pozdnyakova O; Orazi A; Kelemen K; King R; Reichard KK; Craig FE; Quintanilla-Martinez L; Rimsza L; George TI; Horny HP; Wang SA
Am J Clin Pathol; 2021 Feb; 155(2):160-178. PubMed ID: 33367495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
